| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 34 | 2018 | Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals | Tournoy, Kurt G.; THOMEER, Michiel; Germonpre, Paul; Derijcke, Sofie; De Pauw, Rebecca; Galdermans, Daniella; Govaert, Karl; Govaerts, Elke; Schildermans, Rob; Declercq, Isabelle; De Brucker, Nele; Pat, Karin; Van Herreweghe, Rika; Van Zandweghe, Luc; Vanmaele, Luc; Van Damme, Valerie; Marien, Heidi; De Craene, Sofie; Fabry, Isabelle; Alexander, Patrick; Vercauter, Piet; Demedts, Ingel | Journal Contribution | A1 |
| 35 | 2018 | NMR-metabolomics to predict therapy response of resectable lung cancer: The Prolung Project | DERVEAUX, Elien; VANHOVE, Karolien; REEKMANS, Gunter; MESOTTEN, Liesbet; THOMEER, Michiel; ADRIAENSENS, Peter | Conference Material | C2 |
| 36 | 2018 | Prognostic value of total lesion glycolysis and metabolic active tumor volume in non-small cell lung cancer | VANHOVE, Karolien; MESOTTEN, Liesbet; Heylen, Micheline; Derwael, Ruben; LOUIS, Evelyne; ADRIAENSENS, Peter; THOMEER, Michiel; Boellaard, Ronald | Journal Contribution | A1 |
| 37 | 2018 | The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer | VANHOVE, Karolien; GIESEN, Pieter; OWOKOTOMO, Olajumoke Evangelina; MESOTTEN, Liesbet; LOUIS, Evelyne; SHKEDY, Ziv; THOMEER, Michiel; ADRIAENSENS, Peter | Journal Contribution | A1 |
| 38 | 2018 | Diagnosis of lung cancer: what metabolomics can contribute | DERVEAUX, Elien; LOUIS, Evelyne; VANHOVE, Karolien; BERVOETS, Liene; MESOTTEN, Liesbet; THOMEER, Michiel; ADRIAENSENS, Peter | Book Section | B2 |
| 39 | 2017 | Paraneoplastische dermatomyositis | Thijs, L.; Vandepitte, A.; THOMEER, Michiel | Journal Contribution | A1 |
| 40 | 2017 | Zuurstoftoediening bij een acute COPD-exacerbatie: zullen de patiënten werkelijk “stoppen met ademen”? | Bin Saad, M; Bleeser, T; THOMEER, Michiel; JANS, Frank | Journal Contribution | A1 |
| 41 | 2017 | Sarcoidosis around the Globe | Mateyo, Kondwelani; THOMEER, Michiel | Journal Contribution | A1 |
| 42 | 2017 | Metabolic phenotyping of human plasma by H-1-NMR at high and medium magnetic field strengths: a case study for lung cancer | LOUIS, Evelyne; Cantrelle, Francois-Xavier; MESOTTEN, Liesbet; REEKMANS, Gunter; BERVOETS, Liene; VANHOVE, Karolien; THOMEER, Michiel; Lippens, Guy; ADRIAENSENS, Peter | Journal Contribution | A1 |
| 43 | 2016 | Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics | VAN POUCKE, Sven; THOMEER, Michiel; Heath, John; Vukicevic, Milan | Journal Contribution | A1 |
| 44 | 2016 | Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study) | Kreuter, Michael; Vansteenkiste, Johan; Fischer, Jürgen; Eberhardt, Wilfried; Zabeck, Heike; Kollmeier, Jens; Serke, Monika; Frickhofen, Norbert; Reck, Martin; Engel-Riedel, Walburga; Neumann, Silke; THOMEER, Michiel; Schumann, Christian; De Leyn, Paul; Graeter, Thomas; Stamatis, Georgios; Griesinger, Frank; Thomas, Michael | Journal Contribution | A1 |
| 45 | 2016 | Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma | LOUIS, Evelyne; ADRIAENSENS, Peter; GUEDENS, Wanda; BIGIRUMURAME, Theophile; BAETEN, Kurt; VANHOVE, Karolien; Vandeurzen, Kurt; Darquennes, Karen; Vansteenkiste, Johan; Dooms, Christophe; SHKEDY, Ziv; MESOTTEN, Liesbet; THOMEER, Michiel | Journal Contribution | A1 |
| 46 | 2016 | Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types? | LOUIS, Evelyne; ADRIAENSENS, Peter; GUEDENS, Wanda; VANHOVE, Karolien; Vandeurzen, Kurt; Darquennes, Karen; Vansteenkiste, Johan; Dooms, Christophe; DE JONGE, Eric; THOMEER, Michiel; MESOTTEN, Liesbet | Journal Contribution | A1 |
| 47 | 2015 | Prognostic value of quantitative FDG PET/CT uptake metrics in NSCLC | VANHOVE, Karolien; Liesbet, Mesotten; LOUIS, Evelyne; THOMEER, Michiel; ADRIAENSENS, Peter; Boellaard, Ronald | Journal Contribution | M |
| 48 | 2015 | Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer | Pujol, Jean-Louis; Vansteenkiste, Johan F.; De Pas, Tommaso Martino; Atanackovic, Djordje; Reck, Martin; THOMEER, Michiel; Douillard, Jean-Yves; Fasola, Gianpiero; Potter, Vanessa; Taylor, Paul; Bosquee, Lionel; Scheubel, Robert; Jarnjak, Silvija; Debois, Muriel; Alves, Pedro de Sousa; Louahed, Jamila; Brichard, Vincent G.; Lehmann, Frederic F. | Journal Contribution | A1 |
| 49 | 2015 | Metabolomics a novel biomarker in lung cancer | STINKENS, Kirsten; VANHOVE, Karolien; THOMEER, Michiel | Journal Contribution | A1 |
| 50 | 2015 | 2015, big data in healthcare: for whom the bell tolls? | VAN POUCKE, Sven; THOMEER, Michiel; HADZIC, A | Journal Contribution | A1 |
| 51 | 2015 | Validation of 1H-NMR-based metabolomics as a new, complementary tool for the detection of lung cancer via human blood plasma | LOUIS, Evelyne; VANHOVE, Karolien; STINKENS, Kirsten; MESOTTEN, Liesbet; REEKMANS, Gunter; GUEDENS, Wanda; Vandeurzen, Kurt; Sadowska, Anna; Vansteenkiste, Johan; Dooms, Christophe; THOMEER, Michiel; ADRIAENSENS, Peter | Conference Material | C2 |
| 52 | 2015 | Phenotyping human blood plasma by 1H-NMR: a robust protocol based on metabolite spiking and its evaluation in breast cancer | LOUIS, Evelyne; BERVOETS, Liene; REEKMANS, Gunter; DE JONGE, Eric; MESOTTEN, Liesbet; THOMEER, Michiel; ADRIAENSENS, Peter | Journal Contribution | A1 |
| 53 | 2015 | Influence of preanalytical sampling conditions on the 1 H NMR metabolic profile of human blood plasma and introduction of the Standard PREanalytical Code used in biobanking | BERVOETS, Liene; LOUIS, Evelyne; REEKMANS, Gunter; MESOTTEN, Liesbet; THOMEER, Michiel; ADRIAENSENS, Peter; LINSEN, Loes | Journal Contribution | A1 |
| 54 | 2015 | Lung Cancer Can Be Detected By Metabolic Changes In Blood Plasma | LOUIS, Evelyne; VANHOVE, Karolien; MESOTTEN, Liesbet; REEKMANS, Gunter; GUEDENS, Wanda; Vandeurzen, Kurt; Sadowska, Anna; Vansteenkiste, Johan; Dooms, Christophe; THOMEER, Michiel; ADRIAENSENS, Peter | Conference Material | C2 |
| 55 | 2015 | Validation of 1H-NMR spectroscopy as a tool to detect lung cancer in human blood plasma | LOUIS, Evelyne; VANHOVE, Karolien; MESOTTEN, Liesbet; REEKMANS, Gunter; GUEDENS, Wanda; Vandeurzen, Kurt; Sadowska, Anna; Vansteenkiste, Johan; Dooms, Christophe; THOMEER, Michiel; ADRIAENSENS, Peter | Conference Material | C2 |
| 56 | 2015 | Metabolic phenotyping of human blood plasma: a powerful biomarker to discriminate between cancer types? | LOUIS, Evelyne; VANHOVE, Karolien; STINKENS, Kirsten; MESOTTEN, Liesbet; REEKMANS, Gunter; GUEDENS, Wanda; Vandeurzen, Kurt; Sadowska, Anna; Vansteenkiste, Johan; Dooms, Christophe; DE JONGE, Eric; THOMEER, Michiel; ADRIAENSENS, Peter | Conference Material | C2 |
| 57 | 2014 | LINGUISTIC CORRECTION EVALUATION OF 1H-NMR SPECTROSCOPY IN PREDICTING PLATINE-RELATED TOXICITIES IN LUNG CANCER PATIENTS | VANHOVE, Karolien; THOMEER, Michiel; MESOTTEN, Liesbet; LOUIS, Evelyne; ADRIAENSENS, Peter | Journal Contribution | M |
| 58 | 2014 | Prognostische waarde van totale lesie glycolyse en metabool actieve tumor volume in niet kleincellige longkanker | VANHOVE, Karolien; HEYLEN, Rene; Derwael, Ruben; LOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; ADRIAENSENS, Peter; Boellaard, Ronald | Conference Material | C2 |
| 59 | 2014 | Validation of 1H-NMR-based metabolomics as a tool to detect lung cancer in human blood plasma | LOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; VANHOVE, Karolien; Vandeurzen, Kurt; Sadowska, Anna; REEKMANS, Gunter; ADRIAENSENS, Peter | Conference Material | C2 |
| 60 | 2014 | Validation of 1H-NMR-based metabolomics as a tool to detect lung cancer in human blood plasma | LOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; VANHOVE, Karolien; Vandeurzen, Kurt; Sadowska, Anna; REEKMANS, Gunter; ADRIAENSENS, Peter | Conference Material | C2 |
| 61 | 2014 | Prognostic value of total lesion glycolysis and metabolic tumor volume in non-small cell lung cancer | VANHOVE, Karolien; Heylen, Micheline; Derwael, Ruben; LOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; ADRIAENSENS, Peter; Boellaard, Ronald | Journal Contribution | M |
| 62 | 2014 | Validation of 1H-NMR-based metabolomics as a tool to detect lung cancer in human blood plasma | THOMEER, Michiel; LOUIS, Evelyne; MESOTTEN, Liesbet; VANHOVE, Karolien; Vandeurzen, K.; Sadowska, A.; REEKMANS, Gunter; ADRIAENSENS, Peter | Journal Contribution | M |
| 63 | 2014 | Opsporen van longkanker met behulp van een 1H-NMR spectroscopische analyse van bloedplasma | LOUIS, Evelyne; THOMEER, Michiel; MESOTTEN, Liesbet; VANHOVE, Karolien; Vandeurzen, Kurt; Sadowska, Anna; REEKMANS, Gunter; ADRIAENSENS, Peter | Conference Material | C2 |
| 64 | 2013 | Profylaxe tegen Pneumocystis jiroveci-pneumonie: Nuttig bij patiënten zonder hiv-infectie of transplantatie? | Huskens, M.; THOMEER, Michiel; MEEUWISSEN, Joris | Journal Contribution | A1 |
| 65 | 2013 | Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study | Kreuter, M; Vansteenkiste, J; Fischer, J; Eberhardt, W; Zabeck, H; Kollmeier, J; Serke, M; Frickhofen, N; Reck, M; Engel-Riedel, W; Neumann, S; THOMEER, Michiel; Schumann, C; De Leyn, P; Graeter, T; Stamatis, G; Zuna, I; Griesinger, F; Thomas, M | Journal Contribution | A1 |
| 66 | 2013 | Methotrexate vs Azathioprine in Second-line Therapy of Sarcoidosis | Vorselaars, Adriane D. M.; Wuyts, Wim A.; Vorselaars, Veronique M. M.; Zanen, Pieter; Deneer, Vera H. M.; Veltkamp, Marcel; THOMEER, Michiel; van Moorsel, Coline H. M.; Grutters, Jan C. | Journal Contribution | A1 |